• Activity INFORMATION

  Overview

  As rates of polypharmacy rise and medication regimens become more complex, the risk of potential CYP-mediated drug-drug interactions is continuously growing. Additionally, the understanding of polymorphism and epigenetics provides insight into how changes in CYP genes may be responsible for inter-individual variations in these interactions, disease susceptibility, and the therapeutic efficacy of drugs. Cytochrome P450 System Part II reviews genetic polymorphishsms of the P450 system, CYP-drug interactions, and disease progression related to the P450 system.

  Note: this program is available in two formats. For the printout, please click the link marked as handout. For an interactive web page, please click the URL option to access the direct link.

  
  

  Handouts

  • Slide Document :   CYP450 Part II Handout.pdf Download

  • Homestudy PDF :   CYP Part II Link.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Define polymorphism in the CYP enzyme family and its clinical impact

  Identify clinically significant CYP drug interactions, catalysis, and disease progression

  Recognize how to identify and address possible CYP-mediated drug interactions and implement strategies to reduce them during therapy

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-995196

  Universal Activity Number

  Pharmacist 0798-0000-23-073-H01-P
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Fatima  Khaja, CDE, PharmD, PhD Volunteer Pharmacist, CommunityHealth

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).